Nonavalent Human Papillomavirus Vaccine

null · Beijing Health Guard Biotechnology, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nonavalent Human Papillomavirus Vaccine, covering 2024-01-23 to 2024-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine [Phase 3]